1-12 of 12
Authors: Margaret Johnson
Journal Article
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2361–2365, https://doi.org/10.1093/jac/dkad247
Published: 04 August 2023
Journal Article
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 9, September 2021, Pages 2380–2393, https://doi.org/10.1093/jac/dkab158
Published: 13 June 2021
Journal Article
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 4, April 2016, Pages 1056–1062, https://doi.org/10.1093/jac/dkv427
Published: 24 December 2015
Journal Article
Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 10, October 2013, Pages 2339–2343, https://doi.org/10.1093/jac/dkt199
Published: 27 May 2013
Journal Article
Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring Get access
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 6, June 2013, Pages 1354–1359, https://doi.org/10.1093/jac/dkt029
Published: 23 February 2013
Journal Article
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 8, August 2011, Pages 1886–1896, https://doi.org/10.1093/jac/dkr171
Published: 30 May 2011
Journal Article
Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the CYP2B6 516 TT polymorphism
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 3, March 2011, Page 688, https://doi.org/10.1093/jac/dkq534
Published: 06 January 2011
Journal Article
Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 2, February 2011, Pages 363–370, https://doi.org/10.1093/jac/dkq457
Published: 09 December 2010
Journal Article
Factors influencing lopinavir and atazanavir plasma concentration Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 129–137, https://doi.org/10.1093/jac/dkp408
Published: 06 November 2009
Journal Article
Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the CYP2B6 516 TT polymorphism Get access
Journal of Antimicrobial Chemotherapy, Volume 62, Issue 6, December 2008, Pages 1188–1190, https://doi.org/10.1093/jac/dkn374
Published: 10 September 2008
Journal Article
A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study) Get access
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 2, February 2005, Pages 246–251, https://doi.org/10.1093/jac/dkh515
Published: 01 February 2005
Journal Article
The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile Get access
Journal of Antimicrobial Chemotherapy, Volume 15, Issue 3, March 1985, Pages 319–326, https://doi.org/10.1093/jac/15.3.319
Published: 01 March 1985
